Monoamine oxidase inhibitors long-term effects

Virtually all types of drug that have been shown to be effective in major depression exert profound effects on the functioning of the serotoninergic or noradrenergic systems, or both. Although some treatments have been shown to decrease the sensitivity of certain postsynaptic 5-HT and NE receptors, it is generally believed that it is an enhancement of neurotransmission in these systems that is responsible for the improvement of the core symptoms of depression. For instance, long-term administration of tricyclic antidepressants (TCAs) or monoamine oxidase inhibitors (MAOIs) decreases the density of (3-adrenoceptors and cortical 5-HT2 receptors (Blier and Abbott 2003). 

R.L. Sherry, R.T. Courts, G.B. Baker, Fluorotranylcypromine, a novel monoamine oxidase inhibitor. Neurochemical effects in rat brain after short- and long-term administration. Drug Dev. Res. 48 (1999) 61-69. 

Tyrer P. Clinical effects of abrupt withdrawal from tricyclic antidepressants and monoamine oxidase inhibitors after long-term treatment. J Affect Disord 1984 6(l) l-7. 

---